Candidate surname
Other names
Total Marks
Centre Number
Candidate Number
Please check the examination details below before entering your candidate information
Pearson Edexcel 
International
Advanced Level
Thursday 11 June 2020
Paper Reference WBI15/01
Morning (Time: 1 hour 45 minutes)
Biology
Advanced
Unit 5: Respiration, Internal Environment, 
Coordination and Gene Technology
You must have:
A copy of the scientific article (enclosed), scientific calculator,  
HB pencil, ruler.
*P64728A0128*
P64728A
©2020 Pearson Education Ltd.
1/1/1/1/
Turn over    
Instructions
•	Use black ink or ball-point pen.
•	Fill in the boxes at the top of this page with your name,  
centre number and candidate number.
•	Answer all questions.
•	Answer the questions in the spaces provided  
– there may be more space than you need.
•	Show all your working calculations and include units where appropriate.
Information
•	The total mark for this paper is 90.
•	The marks for each question are shown in brackets 
– use this as a guide as to how much time to spend on each question.
•	In questions marked with an asterisk (*), marks will be awarded for your ability 
to structure your answer logically, showing how the points that you make are 
related or follow on from each other where appropriate.
Advice
•	Read each question carefully before you start to answer it.
•	Try to answer every question.
•	Check your answers if you have time at the end.
PMT


--- Page Break ---

2
*P64728A0228*
	
Answer ALL questions. 
Write your answers in the spaces provided.
Some questions must be answered with a cross in a box .  If you change your mind about an 
answer, put a line through the box 
 and then mark your new answer with a cross .
1	 In cells, energy can be released from substrates by anaerobic and aerobic respiration.
	
(a)	 Most eukaryotic cells can respire anaerobically.
	
	
(i)	 Which of the following describes a step in the process of anaerobic respiration?
(1)
	
	
	
A	 decarboxylation of lactate 
	
	
	
B	 phosphorylation of hexoses
	
	
	
C	 oxidation of pyruvate
	
	
	
D	 removal of phosphate groups from glucose
	
	
(ii)	 What happens to the lactate concentration during a period of anaerobic respiration? 
(1)
	
	
	
A	 decreases, causing a decrease in blood pH
	
	
	
B	 decreases, causing an increase in blood pH
	
	
	
C	 increases, causing a decrease in blood pH
	
	
	
D	 increases, causing an increase in blood pH
PMT


--- Page Break ---

3
*P64728A0328*
Turn over    
	
	
(b)	 Most eukaryotic cells are also able to respire aerobically.
	
	
(i)	 How do respiratory substrates enter the Krebs cycle?
(1)
	
	
	
A	 as molecules containing 2 carbon atoms produced by the link reaction
	
	
	
B	 as molecules containing 3 carbon atoms produced by the link reaction
	
	
	
C	 as molecules containing 2 carbon atoms produced by RUBISCO
	
	
	
D	 as molecules containing 3 carbon atoms produced by RUBISCO
	
	
(ii)	 Draw a diagram of a mitochondrion.  
	
	
	
Label only the part of the mitochondrion where the Krebs cycle occurs.
(2)
PMT


--- Page Break ---

4
*P64728A0428*
	
	
	
(iii)	Describe the role of chemiosmosis in the synthesis of ATP.
(5)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 1 = 10 marks)
PMT


--- Page Break ---

5
*P64728A0528*
Turn over    
	
2	 The kidney is an organ involved in the excretion of waste materials and in the 
regulation of blood volume and plasma concentration.
	
(a)	 The functional unit of the kidney is the nephron.
	
	
The diagram shows a single nephron.
W
X
Y
Z
	
	
(i)	 In which part of the kidney are structures W and X located?
(1)
	
	
	
A	 cortex
	
	
	
B	 inner medulla 
	
	
	
C	 outer medulla
	
	
	
D	 renal pelvis
	
	
(ii)	 In which structure does ultrafiltration take place? 
(1)
	
	
	
A	 W
	
	
	
B	 X 
	
	
	
C	 Y
	
	
	
D	 Z
PMT


--- Page Break ---

6
*P64728A0628*
	
	
	
(iii)	Which structures form part of the loop of Henle?
(1)
	
	
	
A	 X only
	
	
	
B	 X and Y 
	
	
	
C	 Y only
	
	
	
D	 Y and Z
	
(b)	 Urea is a toxic substance that is excreted from the body.
	
	
Explain how ultrafiltration removes urea from the blood.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

7
*P64728A0728*
Turn over    
	
	
(c)	 The kidney controls blood volume and plasma concentration by regulating the 
loss of water in urine.
	
	
Some mammals have adaptations to their kidneys that enable them to live in 
different habitats.  
	
	
The table shows information about two small mammals.
Mammal
Urine 
concentration 
/ mOsmol dm−3
Relative number of 
mitochondria in the 
thick ascending loop 
of Henle
Sodium ion concentration 
of extracellular fluid in  
the medulla 
/ mmol dm−3
brown rat
2900
3.6
45
kangaroo rat
5500
5.5
95
	
	
Deduce why the kangaroo rat is more successful than the brown rat at living in 
desert habitats.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 2 = 8 marks)
PMT


--- Page Break ---

8
*P64728A0828*
	
BLANK PAGE
PMT


--- Page Break ---

9
*P64728A0928*
Turn over    
	
3	 Ecstasy (MDMA) is a recreational drug that can have serious toxic effects.
	
(a)	 The effect of MDMA on ADH concentration in blood has been studied.
	
	
In one study, each person in a group of volunteers was given MDMA. The MDMA 
and ADH concentrations in the blood were measured. 
	
	
The graph shows the results of this study.
0
5
10
15
20
25
30
35
40
45
50
0
6
12
18
24
MDMA
ADH
0
1
2
3
4
5
Time / hours
MDMA
concentration
in the blood
/ µg dm−3
ADH
concentration  
in the blood
/ pmol dm−3
	
	
(i)	 Estimate how long it takes the MDMA concentration in the blood to become 
0.0 µg dm−3.
(1)
Answer .............................................................. hours
	
	
(ii)	 Calculate the rate of removal of ADH from the blood between 4 and 8 hours.
(2)
Answer ..............................................................
PMT


--- Page Break ---

10
*P64728A01028*
	
	
*(b)	Taking MDMA causes a person to be very thirsty. This can lead to swelling of the 
brain, which can be fatal.
	
	
The table shows some laboratory results for one case in which a person suffered 
swelling of the brain.
Time since 
taking MDMA
/ hours
ADH concentration
/ pmol dm−3
Sodium ion concentration 
in the blood
/ mmol dm−3
Appearance of the 
brain in computed 
tomography (CT)
  9
4.5
112
Swollen
96
1.2
131
Normal
PMT


--- Page Break ---

11
*P64728A01128*
Turn over    
	
	
	
Comment on the role of ADH in MDMA-induced brain swelling.
	
	
Use the information in the graph and table as well as your own knowledge to 
support your answer.
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 3 = 9 marks)
PMT


--- Page Break ---

12
*P64728A01228*
	
4	 Many people swim as part of their regular exercise.
	
(a)	 The table gives some information about the effect of the intensity of exercise on 
heart rate.
Intensity of 
exercise / a.u.
Heart rate 
/ bpm
4 
118
6
120
8
138
10
150
12
155
14
160
	
	
Describe the relationship between the intensity of exercise and heart rate.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

13
*P64728A01328*
Turn over    
	
	
(b)	 Regular swimming affects resting heart rate and cardiac output.
cardiac output = stroke volume × heart rate 
	
	
The table shows the mean resting cardiac output and mean resting stroke volume 
for a group of regular swimmers and a control group.
Group
Mean resting 
cardiac output
/ dm3 min–1
Mean resting 
stroke volume
/ cm3
Regular swimmers
4.43
74.40
Control
4.21
58.40
	
	
Using the data in the table, calculate the difference in resting heart rate between 
these two groups.
	
	
Give your answer to 2 decimal places with appropriate units.
(3)
Answer ..............................................................
PMT


--- Page Break ---

14
*P64728A01428*
	
	
*(c)	Explain the role of the heart in responding to regular exercise. 
	
	
Use the information in both tables and your own knowledge to support your answer.
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 4 = 11 marks)
PMT


--- Page Break ---

15
*P64728A01528*
Turn over    
	
5	 The eye is a sense organ specialised for detecting light stimuli.
	
(a)	 Pupils of the eye react to light.
	
	
The effects of different light intensities from two light sources have been investigated. 
	
	
The table shows the results of this investigation.
Light intensity
/ a.u. per m2
Mean pupil diameter / mm
Incandescent light
LED light
0
25.5
25.5
75
24.0
22.0
150
24.0
18.5
200
23.0
17.5
300
21.5
16.0
650
17.5
12.0
1400
16.0
9.5
	
	
(i)	 Describe the relationship between light intensity and pupil diameter.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

16
*P64728A01628*
	
	
	
(ii)	 Calculate the amount of incandescent light that can pass through the pupil 
when the light intensity is 1400 a.u. per m2.
	
	
	
Use a value of pi (π) = 3.14
(3)
Answer ..............................................................
	
	
(iii)	Describe how light entering the eye causes the pupil to respond.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

17
*P64728A01728*
Turn over    
	
	
(b)	 Age-related macular degeneration (AMD) is a common cause of blindness in  
older people.
	
	
In AMD the epithelial layer behind the retina is damaged.
	
	
A new treatment for AMD uses induced pluripotent stem cells. These cells are 
grown in a culture to produce a retinal epithelial layer. 
	
	
This retinal epithelial layer can then be used to replace the damaged layer of cells.
	
	
The procedure is outlined in the flow chart.
Collect skin cells from the patient
Induce the skin cells to form 
pluripotent stem cells
Stimulate the stem cells to form a 
retinal epithelial layer
Place the retinal epithelial layer 
behind the retina of the same patient
	
	
(i)	 State what is meant by the term pluripotent stem cell.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

18
*P64728A01828*
	
	
	
(ii)	 The epithelial layer is checked to ensure that there are no stem cells present 
before it is placed in the eye of the patient.
	
	
	
Suggest why this check is carried out.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 5 = 13 marks)
PMT


--- Page Break ---

19
*P64728A01928*
Turn over    
	
6	 Many predatory animals produce toxins to disable their prey.  Some of these toxins 
inhibit nervous communication.
	
(a)	 Nerve impulses are transmitted along axons. Some axons are myelinated.
	
	
(i)	 Which type of cell produces myelin?
(1)
	
	
	
A	 neurone
	
	
	
B	 rod cell
	
	
	
C	 Schwann cell
	
	
	
D	 lymphocyte
	
	
(ii)	 Which row correctly compares the conduction of an impulse along a 
myelinated neurone with conduction along a non-myelinated neurone?
(1)
Compared with a non-myelinated 
neurone the speed of conduction in 
a myelinated neurone is
Because membrane depolarisation 
only takes place in the axon 
membrane
A
faster
at nodes of Ranvier
B
faster
in between nodes of Ranvier 
C
slower
at nodes of Ranvier
D
slower
in between nodes of Ranvier 
PMT


--- Page Break ---

20
*P64728A02028*
	
	
(b)	 Describe the role of ion transport in maintaining the resting potential of a neurone.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

21
*P64728A02128*
Turn over    
	
	
(c)	 The pufferfish produces a neurotoxin called tetrodotoxin (TTX).
	
	
The graph shows the effect of TTX on the nerve impulse in an axon. 
−70
0
+50
Membrane
voltage / mV
Time
untreated axon
TTX treated axon
	
	
Deduce how TTX inhibits nerve impulses in an axon.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 6 = 9 marks)
PMT


--- Page Break ---

22
*P64728A02228*
	
7	 Parkinson’s disease occurs when dopamine-producing neurones die.
	
(a)	 The most obvious motor symptoms of Parkinson’s disease include muscle tremors 
and muscle rigidity.
	
	
These motor symptoms are linked to the loss of dopamine-producing neurones in 
the brain.
	
	
(i)	 One drug used to treat Parkinson’s disease is L-DOPA.
	
	
	
Which of the following statements explains why L-DOPA can be used to treat 
Parkinson’s disease?
(1)
	
	
	
A	 L-DOPA acts on a different post-synaptic receptor to dopamine 
	
	
	
B	 L-DOPA crosses the blood-brain barrier and is then converted to dopamine 
in the brain 
	
	
	
C	 L-DOPA is converted to dopamine in the blood and then crosses the  
blood-brain barrier
	
	
	
D	 L-DOPA is identical to dopamine
PMT


--- Page Break ---

23
*P64728A02328*
Turn over    
	
	
	
(ii)	 Explain why the release of reduced quantities of dopamine by presynaptic 
neurones could result in motor symptoms.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(b)	 It has been suggested that in Parkinson’s disease dopamine-producing neurones 
die because of a failure to release dopamine.
	
	
Suggest how the release of dopamine from presynaptic neurones could be inhibited.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

24
*P64728A02428*
	
	
(c)	 Describe how microarrays and bioinformatics could be used to investigate the 
genetic basis of Parkinson’s disease.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 7 = 10 marks)
PMT


--- Page Break ---

25
*P64728A02528*
	
Turn over    
8	 The scientific document you have studied is adapted from an article in National 
Geographic: How personalized medicine is transforming your health care.
	
Use the information from the scientific document and your own knowledge to 
answer the following questions.
	
(a)	 Explain what is meant by the phrase ‘gene variants’ (paragraph 4).
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(b)	 Explain why ‘tumors ... riddled with different mutations’ are good candidates for 
immunotherapies (paragraph 6).
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

26
*P64728A02628*
	
	
(c)	 Explain why a CT scan was used to show that Judy Perkins was free of tumours 
(paragraph 10 and Figure 1).
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(d)	 Checkpoints are a type of protein that prevent the activation of immune cells. 
	
	
Explain why a checkpoint inhibitor was given with the lymphocytes in the 
immunotherapy used to treat Judy Perkins (paragraph 10). 
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

27
*P64728A02728*
	
	
(e)	 Explain how ‘a gene variant that produces a defective form of an enzyme’ reduces 
the effectiveness of clopidogrel (paragraph 16).
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(f)	 Researchers have used stem cells to produce spinal cord tissue from individuals 
with amyotrophic lateral sclerosis.
	
	
These functioning tissues contain motor neurones and blood vessels.
	
	
Suggest why blood vessels are required to form functioning spinal cord tissue 
(paragraph 31).
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
Turn over    
PMT


--- Page Break ---

28
*P64728A02828*
	
	
(g)	 Suggest how ‘a brew of growth factors and other proteins’ can stimulate induced 
pluripotent stem cells to produce a functioning tissue (paragraph 33).
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 8 = 20 marks)
TOTAL FOR PAPER = 90 MARKS
PMT
